If your stool color has changed because of a change in diet and there are no other symptoms, no treatment is needed
The ongoing financial commitment is an important consideration when starting treatment
Additionally, your doctor will assess whether Ozempic is the best option for managing your type 2 diabetes or assisting with weight loss
Additionally, the GLP-1R/glucagon receptor (GCGR) dual agonist, managed by Innovent Biologics and Eli Lilly, has reached Phase III clinical trials in China with type 2 diabetes patients, demonstrating significant reductions in blood sugar, weight loss, and cardiovascular and kidney benefits
One of the key roles of Breakthrough T1D is funding the research and hoping that our funding will remove that initial barrier of entry. Several trials on the horizon are testing new treatments for type 1 diabetes